To test this hypothesis, we performed H&E staining and immunofluorescence for FOXM1 and Ki-67, a marker of cell proliferation, on 13 spatially defined samples from 5 tumors comprising all meningioma grades (Fig. 4a and Supplementary Data 2). The gene discussed is MKI67; the disease is meningioma.